A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity. The starting dose ...
From viral food videos to heated nutrition debates and the rise of weight-loss drugs, a number of forces in 2025 reshaped how Americans eat. More people turned to influencers for food advice, plus ...
Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...
The Mediterranean diet’s colder-climate cousin comes with the same health benefits thanks to its combination of anti-inflammatory- and antioxidant-rich foods. Fatty fish like salmon are a key ...
Share on Pinterest Adherence to the Portfolio Diet may reduce the risk of death from heart disease by 18%. Image Credit: Ina Peters/Stocksy Research has linked adherence to the Portfolio Diet with a ...
The best weight loss supplements for women may include magnesium, caffeine, green tea, protein, fiber, and vitamin B12. The FDA doesn’t closely regulate supplements, so they’re not guaranteed to be ...
NEW YORK, Dec 24 (Reuters) - Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, appetite-suppressing GLP-1 pills become ...
The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 ...
The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...
You can always count on social media to churn out another hack promising health results like you’ve never seen before. The 90-30-50 diet making the rounds on TikTok is no exception. Unlike diets that ...
A new weight-loss drug that Eli Lilly is testing is helping patients in a late-stage trial lose an average of 28.7% of their body weight and offered "substantial" relief from osteoarthritis pain. In ...
Eli Lilly LLY-0.35%decrease; red down pointing triangle said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results